<DOC>
	<DOCNO>NCT00040495</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety intravenous pantoprazole prevention rebleeding patient bleed peptic ulcer disease successful endoscopic hemostatic therapy .</brief_summary>
	<brief_title>Study Evaluating Pantoprazole Peptic Ulcer Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients must men nonpregnant woman least 18 year age Patients present gastric duodenal ulcer Patients ulcer appearance clean base ( nonoozing , nonspurting ) flat pigment spot ; adherent clot remove irrigation Patients present active bleeding and/or NBVV 2 separate site Patients severe concomitant disease , eg , end stage liver renal disease , unstable cardiovascular , pulmonary , renal , hepatic , gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Peptic</keyword>
	<keyword>Ulcer</keyword>
	<keyword>Hemorrhage</keyword>
</DOC>